Archive for April 24th, 2012

Do monkeys eat Pringles?

April 24, 2012

Excerpted from the NY Times When a Sugar High Isn’t Enough

Dr. John Kellogg — founder of the world’s largest cereal company had a simple  credo:  “Eat what the monkey eats …  simple food and not too much of it.”

Do monkeys eat Pringles?

Hope so because Kellogg is buying Pringles from Procter & Gamble in a $2.7 billion deal expected to close this summer.

Why?

For openers, Kellogg’s legacy brands (Corn Flakes and Rice Krispies) are under pressure from private labels and other breakfast convenience foods.

Note: Kellogg cranks out about 200 million pounds of private-label cereal a year.  

The real growth for Kellogg, as well as for packaged-food rivals like PepsiCo and its Frito-Lay division, is foreign markets and snacks.  That’s where Pringles comes in.

Kellogg’s CEO says that selling cereal and selling snacks are two entirely different skills.

What the company is buying with Pringles is not just a line of products that is already huge internationally, but a group of Procter & Gamble merchandisers with “the snack mind-set.” 

“When you’re talking about snacks … it’s about someone who came into the store to buy something else and hit a display and thinks, ‘Hey, I’d love to have a can of Pringles.’

With snacks, it’s much more intercepting the consumer in-store as opposed to getting on their shopping list.

It’s in-store merchandising.

It’s retail entertainment.

Whereas cereal is much more about the 30-second feel-good ad.” 

* * * * *
Nutrition note: According to  Robert H. Lustig, a professor of clinical pediatrics at the University of California, San Francisco:

”People who consume sugar are more likely to overeat because “there are signals to the brain that tell you when you’ve had enough; sugar blocks them.

Eating calories from sugar will therefore lead you to consume more calories.”

 Thanks to DM for feeding the lead

>> Latest Posts

WSJ: Lab Mistakes Hobble Cancer Studies …

April 24, 2012

Punch line: Many scientists work has been undermined by the contamination and misidentification of cancer cell lines used in research labs around the world.

* * * * *
Excerpted from the WSJ

Cancer experts seeking to solve the problem have found that a fifth to a third or more of cancer cell lines tested were mistakenly identified —with researchers unwittingly studying the wrong cancers, slowing progress toward new treatments and wasting precious time and money.

In hundreds of documented cases that undermine a broad swath of research, cancer samples that were supposed to be one type of tumor have turned out to be another, through either careless laboratory handling, mislabeling or other mistakes.

These mix-ups are maddeningly difficult to pinpoint: an improperly sterilized pipette, a lab worker momentarily distracted, a misread label or a typo on a record sheet.

When seeking cancer treatment for a specific tumor, he said, such mistakes “are an utter waste of public money, charity money and time.”

“It may be causing drugs to be used which are inappropriate for that particular type of cancer.”

The problem is particularly damaging for research into such rare cancers as adenoid cystic carcinoma, which strikes 1,200 people in the U.S. each year. The lack of a good cell line slows research and few in the field have the time or resources to create new lines.

Seeking to solve the problem, a committee led by ATCC, a nonprofit group based in Manassas, Va., released guidelines this year to establish standards to authenticate cancer cell lines.

ATCC is working with the National Center for Biotechnology Information, a branch of the National Institutes of Health, to establish a central repository and database of cell lines that have undergone genetic testing and whose origins can be verified.

>> Latest Posts